FDA Inspection 1193444 — UPMC Harrisburg
The FDA completed an inspection of UPMC Harrisburg on December 14, 2022 in Harrisburg, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 14, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Harrisburg, PA (United States)